The JAK2 pathway is activated in idiopathic pulmonary fibrosis
Abstract Background Idiopathic pulmonary fibrosis (IPF) is the most rapidly progressive and fatal fibrotic disorder, with no curative therapies. The signal transducer and activator of transcription 3 (STAT3) protein is activated in lung fibroblasts and alveolar type II cells (ATII), thereby contribu...
Main Authors: | Javier Milara, Gracia Hernandez, Beatriz Ballester, Anselm Morell, Inés Roger, P. Montero, Juan Escrivá, José M. Lloris, Maria Molina-Molina, Esteban Morcillo, Julio Cortijo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-018-0728-9 |
Similar Items
-
Heterogeneity in Fibroblast Proliferation and Survival in Idiopathic Pulmonary Fibrosis
by: David Michael Habiel, et al.
Published: (2014-01-01) -
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
by: Paula Montero, et al.
Published: (2021-06-01) -
Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
by: Qianru Mei, et al.
Published: (2022-01-01) -
The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
by: Inés Roger, et al.
Published: (2021-05-01) -
Circular RNAs and their roles in idiopathic pulmonary fibrosis
by: Akshaya Surendran, et al.
Published: (2024-02-01)